Trial
NCT05702996
Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University Hospital, Rouen
Collaborators
—
Condition
Thrombotic Microangiopathies
Intervention
Eculizumab administration
Why stopped
Change in the molecule
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-09